Singapore markets closed

PFE Jan 2024 45.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
9.600.00 (0.00%)
As of 03:48PM EST. Market open.
Full screen
Loading interactive chart…
  • Reuters

    Pfizer to invest more than $2.5 billion to expand European manufacturing

    Pfizer Inc is investing more than $2.5 billion at its drug making plants in Belgium and Ireland, gearing up to launch new products it hopes can replace lost revenue as patents expire and COVID-19 vaccine sales decline. The drugmaker said on Friday it plans to spend more than 1.2 billion euros ($1.26 billion) to expand its Puurs, Belgium manufacturing site, matching the investment at its Dublin, Ireland plant announced on Thursday. The Puurs site has played a key role in the production of COVID-19 vaccine shots Pfizer developed with its German partner BioNTech using the messenger RNA (mRNA) technology.

  • Zacks

    Pharma Stock Roundup: PFE & AZN Ink New M&A Deals, LLY Meets Alzheimer's Study Goal

    Pfizer (PFE) and Roivant Sciences (ROIV) form a new Roivant subsidiary to develop an inflammatory disease drug. AstraZeneca (AZN) to boost cell therapies portfolio with private company buyout.

  • Motley Fool

    Why Roivant Sciences' Shares Are Up Thursday

    The company is collaborating with Pfizer to create a portfolio company to develop an encouraging drug to treat ulcerative colitis.